Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by coalbeton Sep 22, 2018 2:06pm

64 Views

Post# 28670759

RE:RE:RE:Let’s be patient my friends look at apple

If You Had Invested Right After Apple's IPO (AAPL ...

https://www.investopedia.com/articles/active-trading/080715/if-you...

After Apple issued another two for one stock split, those 90 shares of Apple became 180 shares. Apple closed at $55.62 per share on June 21, 2000, when the investment would have been worth over $10,000. 2005 Two for One Stock Split. On Feb. 28, 2005, Apple issued another two for one stock split, so those 180 shares would double to become 360 shares. Apple closed at $44.86 per share. The initial …

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload